Aura Biosciences | 8-K: Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
Aura Biosciences | DEFA14A: Others
Aura Biosciences | DEF 14A: Definitive information statements
Aura Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Aura Biosciences | 8-K: Current report
Aura Biosciences | S-3: Registration statement for specified transactions by certain issuers
Aura Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aura Biosciences | 8-K: Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences | 8-K: Current report
Aura Biosciences | 8-K: Current report
Aura Biosciences | 8-K: Current report
Aura Biosciences | 8-K: Current report
Aura Biosciences | 8-K: Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | 8-K: Current report
Aura Biosciences | 8-K: Aura Biosciences Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | DEFA14A: Others
Aura Biosciences | DEF 14A: Definitive proxy statements
Aura Biosciences | 8-K: Current report
Aura Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aura Biosciences | 8-K: Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights
No Data